2012
DOI: 10.1016/j.progpolymsci.2011.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Additive manufacturing of tissues and organs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
663
0
17

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 1,040 publications
(707 citation statements)
references
References 171 publications
0
663
0
17
Order By: Relevance
“…Moreover, the ability of SLS to manufacture anatomically shaped scaffolds with designed microstructure made of bioactive and bioresorbable composite materials at high filler loadings allows for fabrication of scaffolds with a high degree of geometric complexity and enables the direct conversion of the digital representation of any object into its physical realisation. The method also enables the development of patient and tissue-specific reconstruction strategies [6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the ability of SLS to manufacture anatomically shaped scaffolds with designed microstructure made of bioactive and bioresorbable composite materials at high filler loadings allows for fabrication of scaffolds with a high degree of geometric complexity and enables the direct conversion of the digital representation of any object into its physical realisation. The method also enables the development of patient and tissue-specific reconstruction strategies [6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…The direct depth-controlled delivery of picoliter doses over two dimensions opens up new possibilities to study local effects of drug or growth factor delivery, for instance in tissue-engineering applications [12]. Furthermore, combining more powerful lasers with viscous inks [33] could potentially enable our device to generate faster microjets for needle-free injection into stiffer tissues or materials than the soft gelatin susbtrate used in this paper.…”
Section: Resultsmentioning
confidence: 98%
“…3b) over a two-dimensional area with a ± 25 μm depth control as well as a ± 4 μm lateral precision and a 12 ± 4 μm lateral dispersion. This micrometric lateral and axial control over the liquid delivery is comparable to the size of a cell and therefore falls within the range of the optimal printing precision for direct three-dimensional delivery of cells or particles [12]. We thus investigate in the next section the ability of our LIFT system to deliver particles at a pinpoint location in a volume.…”
Section: Depth-controlled Injection For Direct Three-dimensional Liqumentioning
confidence: 93%
See 1 more Smart Citation
“…In the most classical approach, known as scaffold-based or top-down, scaffolds are fabricated through either conventional or additive manufacturing processes, and subsequently seeded with autologous or allogeneic cells. The cellular scaffold is then cultured in vitro to produce a tissue-engineered construct for subsequent implantation into the lesion site [66,116,146,177]. Despite the fact that such an approach allows for a good control over the scaffold characteristics (when additive manufacturing processes are used) and cellscaffold interactions, it fails in placing individual cells at specific locations throughout the scaffold, thereby not mimicking the intricate cellular organization of natural tissues at micro-and nanoscale.…”
Section: Introductionmentioning
confidence: 99%